# Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis

> **NCT00391911** · PHASE2 · COMPLETED · sponsor: **Royal Alexandra Hospital** · enrollment: 3 (actual)

## Conditions studied

- Rhabdomyolysis

## Interventions

- **DRUG:** N-Acetylcysteine
- **OTHER:** N-Acetylcystine and Non CRRT
- **OTHER:** Placebo and CRRT
- **OTHER:** Placebo and Non CRRT

## Key facts

- **NCT ID:** NCT00391911
- **Lead sponsor:** Royal Alexandra Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2012-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391911, "Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00391911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*